Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

60.21
+0.54820.92%
Post-market: 60.20-0.0082-0.01%19:30 EDT
Volume:14.83K
Turnover:889.95K
Market Cap:291.41M
PE:19.69
High:60.29
Open:60.11
Low:59.81
Close:59.66
52wk High:64.10
52wk Low:44.47
Shares:4.84M
Float Shares:4.84M
Volume Ratio:0.30
T/O Rate:0.31%
Dividend:1.53
Dividend Rate:2.53%
EPS(TTM):3.06
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Axsome Presents Alzheimer’s Agitation Caregiver Survey Results at Psych Congress 2026

Reuters
·
Sep 21

China-Singapore Suzhou Industrial Park Invests Up to RMB 20 Million in Medical Device and Biotech Fund

Stock News
·
Sep 21

Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks

Stock News
·
Sep 21

Axsome's Auvelity Launch Shows Early Strength in Alzheimer's Agitation, RBC Says

MT Newswires Live
·
Sep 18

Tellgen Corporation's Subsidiaries Obtain Regulatory Approvals for Two Diagnostic Products

Stock News
·
Sep 18

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Sep 18

Roivant Sciences Holds Annual Shareholder Meeting

Reuters
·
Sep 18

Roivant Sciences Director Meghan FitzGerald Reports $203,159 Common Share Sale

Reuters
·
Sep 18

Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300

Reuters
·
Sep 18

US Health Secretary Kennedy Jr. Adds Eight New Members to Key Health Committee

Reuters
·
Sep 17

Guardant Health on Track for Record High Close

Dow Jones
·
Sep 17

Stifel Nicolaus Initiates Roivant Sciences With Buy Rating, $51 Price Target

MT Newswires Live
·
Sep 17

Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026

GlobeNewswire
·
Sep 17

Roivant Sciences Ltd : Stifel Initiates Coverage with Buy Rating; Target Price $51

THOMSON REUTERS
·
Sep 17

Roivant Sciences Price Target Announced at $51.00/Share by Stifel

Dow Jones
·
Sep 17

Roivant Sciences initiated with a Buy at Stifel

TIPRANKS
·
Sep 17

BrightSpring PharMerica President Scott A. Greenwell Sells 15,099 Shares for $874,380.09

Reuters
·
Sep 17

Ulanqab Municipal Market Regulation Bureau Advances Medical Device Quality Control Sampling in 2026

Deep News
·
Sep 16

Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says

MT Newswires Live
·
Sep 16

Revolution Medicines gets orphan designation for pancreatic cancer treatment

TIPRANKS
·
Sep 16